ImmunityBio, Inc.
DE ˙ DB ˙ US45256X1037
6,13 € ↓ -0,04 (-0,65%)
2026-06-03
DEL PRIS
SecurityDE:26CA / ImmunityBio, Inc.
InstitutionMillennium Management Llc
ManagerIsrael Englander
Latest Disclosed Ownership1,420,244 shares
Latest Disclosed Value $ 10,893,271
Millennium Management Llc ownership in 26CA / ImmunityBio, Inc.

On May 15, 2026 - Millennium Management Llc filed a 13F-HR form disclosing ownership of 1,420,244 shares of ImmunityBio, Inc. (DE:26CA) valued at $9,316,801 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 118,428 shares of ImmunityBio, Inc.. This represents a change in shares of 1,099.25% during the quarter. The current value of the position is $8,706,096 USD.

Millennium Management Llc has a history of taking positions in derivatives of the underlying security (26CA) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 23,800 of underlying shares valued at $182,546 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:26CA / ImmunityBio, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F IMMUNITYBIO COM 45256X103 1,420,244 1,301,816 1,099.25 10,893 4,555.13 0.0045
2026-02-17 2025-12-31 13F IMMUNITYBIO COM 45256X103 118,428 70,132 145.21 234 98.31 0.0001
2025-11-14 2025-09-30 13F IMMUNITYBIO COM 45256X103 48,296 -3,195,410 -98.51 119 -98.62 0.0001
2025-08-14 2025-06-30 13F IMMUNITYBIO COM 45256X103 3,243,706 2,813,953 654.78 8,563 562.26 0.0041
2025-05-15 2025-03-31 13F IMMUNITYBIO COM 45256X103 429,753 195,675 83.59 1,294 115.86 0.0007
2025-02-14 2024-12-31 13F IMMUNITYBIO COM 45256X103 234,078 -882,687 -79.04 599 -85.58 0.0003
2024-11-14 2024-09-30 13F IMMUNITYBIO COM 45256X103 1,116,765 1,023,174 1,093.24 4,154 602.88 0.0020
2024-08-14 2024-06-30 13F IMMUNITYBIO COM 45256X103 93,591 39,242 72.20 591 103.09 0.0003
2024-05-15 2024-03-31 13F IMMUNITYBIO COM 45256X103 54,349 -5,959 -9.88 292 -3.64 0.0001
2024-02-14 2023-12-31 13F IMMUNITYBIO COM 45256X103 60,308 16,147 36.56 303 308.11 0.0001
2023-11-14 2023-09-30 13F IMMUNITYBIO COM 45256X103 44,161 44,161 75 0.0000
2023-08-14 2023-06-30 13F IMMUNITYBIO COM 45256X103 0 -520,831 -100.00 0 -100.00
2023-05-15 2023-03-31 13F IMMUNITYBIO COM 45256X103 520,831 520,831 948 0.0005
2023-02-14 2022-12-31 13F IMMUNITYBIO COM 45256X103 0 -399,271 -100.00 0 -100.00
2022-11-14 2022-09-30 13F IMMUNITYBIO COM 45256X103 399,271 -780,514 -66.16 1,984 -54.80 0.0012
2022-08-15 2022-06-30 13F IMMUNITYBIO COM 45256X103 1,179,785 569,696 93.38 4,389 28.22 0.0027
2022-05-16 2022-03-31 13F IMMUNITYBIO COM 45256X103 610,089 332,786 120.01 3,423 103.02 0.0018
2022-02-14 2021-12-31 13F IMMUNITYBIO COM 45256X103 277,303 211,970 324.45 1,686 165.09 0.0009
2021-11-15 2021-09-30 13F IMMUNITYBIO COM 45256X103 65,333 1,686 2.65 636 -30.03 0.0004
2021-08-16 2021-06-30 13F IMMUNITYBIO COM 45256X103 63,647 -10,695 -14.39 909 -48.50 0.0006
2021-05-17 2021-03-31 13F IMMUNITYBIO COM 45256X103 74,342 74,342 16.80 1,765 94.17 0.0013
2021-02-16 2020-12-31 13F NANTKWEST COM 63016Q102 0 -39,865 -100.00 0 -100.00
2020-11-16 2020-09-30 13F NANTKWEST COM 63016Q102 39,865 -128,476 -76.32 276 -86.65 0.0003
2020-08-14 2020-06-30 13F NANTKWEST COM 63016Q102 168,341 -154,658 -47.88 2,067 122.26 0.0028
2020-05-14 2020-03-31 13F NANTKWEST COM 63016Q102 322,999 13,660 4.42 930 -20.65 0.0021
2020-02-14 2019-12-31 13F NANTKWEST COM 63016Q102 309,339 -109,280 -26.10 1,172 129.80 0.0015
2019-11-14 2019-09-30 13F NANTKWEST COM 63016Q102 418,619 -417,140 -49.91 510 -40.14 0.0008
2019-08-15 2019-06-30 13F/A-1 NANTKWEST COM 63016Q102 835,759 798,711 2,155.88 852 1,344.07 0.0013
2019-08-14 2019-06-30 13F NANTKWEST COM 63016Q102 835,759 798,711 852
2019-05-14 2019-03-31 13F NANTKWEST COM 63016Q102 37,048 -81,018 -68.62 59 -56.93 0.0001
2019-02-15 2018-12-31 13F/A-1 NANTKWEST COM 63016Q102 118,066 -7,375 -5.88 137 -70.47 0.0002
2019-02-14 2018-12-31 13F NANTKWEST COM 63016Q102 118,066 137
2018-11-14 2018-09-30 13F NANTKWEST COM 63016Q102 125,441 -74,989 -37.41 464 -24.31 0.0006
2018-08-14 2018-06-30 13F NANTKWEST COM 63016Q102 200,430 43,686 27.87 613 0.49 0.0008
2018-05-15 2018-03-31 13F NANTKWEST COM 63016Q102 156,744 125,544 402.38 610 335.71 0.0008
2018-02-14 2017-12-31 13F NANTKWEST COM 63016Q102 31,200 -4,857 -13.47 140 -29.29 0.0002
2017-11-14 2017-09-30 13F NANTKWEST COM 63016Q102 36,057 -1,883 -4.96 198 -31.25 0.0003
2017-08-14 2017-06-30 13F NANTKWEST COM 63016Q102 37,940 -1,176 -3.01 288 107.19 0.0005
2017-05-15 2017-03-31 13F NANTKWEST COM 63016Q102 39,116 -106,291 -73.10 139 -83.29 0.0003
2017-02-14 2016-12-31 13F NANTKWEST COM 63016Q102 145,407 145,407 832 0.0017
2016-08-15 2016-06-30 13F NANTKWEST COM 63016Q102 0 -23,685 -100.00 0 -100.00
2016-05-16 2016-03-31 13F NANTKWEST COM 63016Q102 23,685 23,685 195 0.0005
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2024-08-14 2024-06-30 13F IMMUNITYBIO COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F IMMUNITYBIO COM Call 100,000 537 n/a n/a n/a
2021-08-16 2021-06-30 13F IMMUNITYBIO COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-05-17 2021-03-31 13F IMMUNITYBIO COM Call 100,000 2,374 n/a n/a n/a
2016-08-15 2016-06-30 13F NANTKWEST COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2016-05-16 2016-03-31 13F NANTKWEST COM Call 50,000 0.00 411 -52.60 n/a n/a n/a
2016-02-16 2015-12-31 13F NANTKWEST COM Call 50,000 867 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F IMMUNITYBIO COM Put 23,800 183 n/a n/a n/a
2024-08-14 2024-06-30 13F IMMUNITYBIO COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F IMMUNITYBIO COM Put 350,000 1,880 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.